Ligand validation:6EYI

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 6EYI designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6EYI_NAG_A_303	71%	73%	0.105	0.926	0.3	0.75	-	1	0	0	100%	0.9333
6EYI_NAG_A_304	61%	63%	0.133	0.921	0.29	1.12	-	1	0	0	100%	0.9333
6EYI_NAG_A_301	40%	74%	0.156	0.868	0.26	0.73	-	1	0	0	100%	0.9333
6EYI_NAG_A_302	15%	76%	0.287	0.851	0.35	0.6	-	-	0	0	100%	0.9333
6EYI_NAG_A_307	10%	75%	0.298	0.81	0.26	0.72	-	1	0	0	100%	0.9333
6EYI_NAG_A_305	5%	68%	0.262	0.671	0.37	0.84	-	1	0	0	100%	0.9333
6EYI_NAG_A_306	2%	53%	0.318	0.611	0.38	1.4	-	3	0	0	100%	0.9333
4C16_NAG_A_284	83%	69%	0.1	0.957	0.37	0.82	-	1	0	0	100%	0.9333
6EYK_NAG_A_301	82%	74%	0.094	0.949	0.27	0.74	-	1	0	0	100%	0.9333
6EYJ_NAG_B_301	74%	67%	0.094	0.924	0.28	0.97	-	2	0	0	100%	0.9333
8R5L_NAG_A_303	69%	71%	0.085	0.898	0.3	0.8	-	-	1	0	100%	0.9333
4CSY_NAG_A_283	69%	70%	0.125	0.939	0.38	0.77	-	-	1	0	100%	0.9333
3H0C_NAG_A_794	100%	56%	0.021	0.995	0.61	1.08	-	1	0	0	100%	0.9333
5F9W_NAG_A_510	100%	88%	0.023	0.994	0.24	0.43	-	-	0	0	100%	0.9333
5LDS_NAG_B_1007	100%	67%	0.022	0.995	0.48	0.79	-	-	0	0	100%	0.9333
5O5D_NAG_A_601	100%	65%	0.022	0.994	0.32	0.99	-	1	0	0	100%	0.9333
6MUG_NAG_G_629	100%	76%	0.022	0.994	0.35	0.58	-	-	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.